This is not only due to the fact that investors are a temperamental bunch. The outcome of the trade disputes has a significant impact on corporate earnings, arguably a key determinant of equity allocation. There still remains uncertainty surrounding the trade conflict, not only between the US and China, but to a large degree between the US and the rest of the world.
This, combined with the intellectual property disputes in information technology, is having an impact on economic activity and earnings across the globe: directly (through higher costs and lower revenues) or indirectly (as companies refrain from spending or investing more). Brexit has been the other topic at the forefront of equity investors’ minds, although its impact is by and large contained to the UK and Continental European equity markets.
Depending on which one of our two scenarios (base case or alternative) develops over the next year, regional allocation in equity portfolios in our opinion should look very different.
Our base case scenario – with no hard Brexit and a slimmed-down version of a US-China trade deal; sufficient to bring back some business confidence, capital expenditures and corporate earnings growth – makes the case for equities outside of the US compelling. The current equity risk premium of US equities is at a 20-year low vis à vis Japan, Europe and emerging markets.
Arguably, US equity markets are discounting a world where US corporates are not only firing on at least most of their cylinders, but also where the rest of the world’s corporates remain far behind. However, a look at the current earnings expectations across major equity markets paints a very different picture. Markets outside the US have already priced in a lot of uncertainty, and earnings growth (or lack thereof) is now at levels that do not justify the wide disparity in valuations.
Take EM, with an expected earnings growth of 2.3% for 2019 and 13.4% for 2020, and a P/E of 13.2x and 11.4x, respectively. This compares with the US’s 2.3% and 10.5% 2019 and 2020 earnings growth and 18.6x and 16.9x P/E, respectively. For Japan, earnings are expected to fall by 0.9% in 2019 and grow 5.8% in 2020, while P/E is at 13.7x and 12.8x, respectively. Europe’s earnings expectations are for a 1.3% and 9.7% growth respectively, priced at a P/E of 14.8x and 13.4x.
The relative earnings outlook is a key driver for regional allocation in equity markets. This is most evident in emerging markets, where their relative performance to developed markets over the long term has coincided with the forward earnings gap (see the graph below).
Of course, for equities outside of the US to outperform, we need their earnings expectations not to fall below their current levels. A poor earnings environment would set markets back on the defensive and quality-seeking path into the arms of US equities. That macro improvement, that is part of our base case scenario, is therefore a key prerequisite to support earnings.
The case for outperformance of non-US equity markets becomes even more compelling given the persistent underperformance that we have witnessed over the last ten years, as shown in the following graph.
In our alternative scenario, which in our view is less likely, we have either no resolution or a meaningful setback in the US-China negotiations, the path to a US recession is already irreversible, and corporate earnings across the world weaken. Such a scenario would most likely bring back the risk-off stance, with global equity markets underperforming other asset classes and, within equities, the US market and more defensive bets most likely prevailing.
Depending on which one of our two scenarios develops over the next year, regional allocation in equity portfolios should look very different. In our base case scenario, the case for equities outside of the US is compelling, given relative earnings growth, valuations and prolonged underperformance. In this scenario, there is no hard Brexit and a slimmed-down version of a US-China trade deal, sufficient to bring back some business confidence, capital expenditures and a return of corporate earnings growth.
Our alternative scenario would most likely bring back the risk-off stance. Within equities, the US market and more defensive bets would probably prevail. That said, we see the risk-reward between the two scenarios as asymmetric. Further degeneration in either the trade war or Brexit is likely to cause a negative price reaction, the latter limited to the UK and Europe. But the upside to non-US equities that would be triggered by positive news at this point looks far greater.
The content displayed on this website is exclusively directed at qualified investors, as defined in the swiss collective investment schemes act of 23 june 2006 ("cisa") and its implementing ordinance, or at “independent asset managers” which meet additional requirements as set out below. Qualified investors are in particular regulated financial intermediaries such as banks, securities dealers, fund management companies and asset managers of collective investment schemes and central banks, regulated insurance companies, public entities and retirement benefits institutions with professional treasury or companies with professional treasury.
The contents, however, are not intended for non-qualified investors. By clicking "I agree" below, you confirm and acknowledge that you act in your capacity as qualified investor pursuant to CISA or as an “independent asset manager” who meets the additional requirements set out hereafter. In the event that you are an "independent asset manager" who meets all the requirements set out in Art. 3 para. 2 let. c) CISA in conjunction with Art. 3 CISO, by clicking "I Agree" below you confirm that you will use the content of this website only for those of your clients which are qualified investors pursuant to CISA.
Representative in Switzerland of the foreign funds registered with the Swiss Financial Market Supervisory Authority ("FINMA") for distribution in or from Switzerland to non-qualified investors is ACOLIN Fund Services AG, Affolternstrasse 56, 8050 Zürich, and the paying agent is UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zürich. Please consult www.finma.ch for a list of FINMA registered funds.
Neither information nor any opinion expressed on the website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco/RobecoSAM AG product should only be made after reading the related legal documents such as management regulations, articles of association, prospectuses, key investor information documents and annual and semi-annual reports, which can be all be obtained free of charge at this website, at the registered seat of the representative in Switzerland, as well as at the Robeco/RobecoSAM AG offices in each country where Robeco has a presence. In respect of the funds distributed in Switzerland, the place of performance and jurisdiction is the registered office of the representative in Switzerland.
This website is not directed to any person in any jurisdiction where, by reason of that person's nationality, residence or otherwise, the publication or availability of this website is prohibited. Persons in respect of whom such prohibitions apply must not access this website.